Tumor entity | Incidence (worldwide 2020) | SCC proportion | Incidence SCC | Proportion of cervical metastasis | Incidence of cervical metastasis | Proportion of all cervical metastases | References |
---|---|---|---|---|---|---|---|
Lung cancer | 2,206,771 | 27.5% | 606,862 | 1.5% | 9,103 | 2% | [21] |
ESCC | 604,000 | 100% | 604,000 | 18.1% | 109,324 | 22% | |
HNSCC—oral cavity | 377,713 | 100% | 377,713 | 60% | 226,628 | 45% | [24] |
HNSCC—larynx | 184,615 | 100% | 184,615 | 50% | 92,308 | 18% | [25] |
HNSCC—oropharynx | 98,412 | 100% | 98,412 | 60% | 59,047 | 12% | [24] |
Non-melanoma skin cancer | 1,198,073 | 13.8% | 1,198,073 | 4% | 6,589 | 1% | [26] |
Total | 502,999 | 100% |